PreEvnt recently announced plans to introduce Isaac, its non-invasive alert device for monitoring blood glucose levels.

The patent litigation relates to the companies’ continuous glucose monitor (CGM) technologies. Abbott and Dexcom are two ...

The FDA has issued a warning letter related to BD Pyxis automated medication dispensing systems — technology that was part of ...

There has been no shortage of news covered across the diabetes and drug delivery markets over the course of 2024.

Vivani Medical (Nasdaq:VANI) announced today that it initiated screening and enrollment for a first-in-human trial of its GLP-1 implant.

Eli Lilly (NYSE:LLY) announced today that the Egyptian Drug Authority approved insulin glargine manufactured in partnership ...

A pickleball player wears the Stelo over-the-counter CGM. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) announced today that it launched a proprietary generative AI platform integrated with its ...